The Problem With Paying Your Intake Team on Signed Cases Alone

Most PI firms pay their intake team a bonus for every case they sign. The logic seems bulletproof: more signed cases means more revenue, so reward the behavior you want to see. The intake rep who signs 30 cases a month gets a bigger check than the one who signs 18. Simple.

Except it is not simple. That incentive structure is quietly creating a problem that shows up months later in your withdrawal rate, your average settlement value, and your cost per case. And by the time you notice it, you have already spent the money.

What Volume-Based Bonuses Actually Reward

When you pay intake reps per signed retainer, you are telling them one thing: get the signature. Every lead that walks through the door becomes a potential bonus. The rep's financial incentive is to close, not to qualify.

This creates predictable behaviors. Reps push harder on leads who are hesitant. They gloss over red flags — pre-existing conditions, questionable liability, soft tissue cases with minimal treatment. They sign the caller who “just wants to see what happens” because that caller is $50 or $100 in their pocket. The rep is not being dishonest. They are doing exactly what you are paying them to do.

The result is a portfolio of signed cases that looks impressive on the intake dashboard and starts to fall apart three to six months later when attorneys review the files.

The Hidden Cost of Marginal Signings

A “marginal signing” is a case that meets the bare minimum criteria to get a retainer signed but has a high probability of withdrawal, early closure, or settlement value below the firm's break-even point. These cases are not free. They consume real resources.

Consider a firm signing 150 cases per month with a 14% withdrawal rate. That is 21 withdrawn cases per month. At $2,000 in wasted development cost per case, the firm is losing $42,000 every month on cases that never produce a dollar of revenue. That is $504,000 per year. Not in missed opportunity — in direct cost.

Now add the cases that do not withdraw but settle for significantly less than the firm's break-even cost per case. A soft tissue case from a low-quality lead source that settles for $8,000 after 14 months of work is not a win. It is a loss dressed up as a resolved case. The intake rep who signed it got their bonus on day one. The firm absorbed the loss more than a year later.

What Quality-Based Metrics Look Like

The alternative is not to stop measuring volume. It is to measure what happens after the signature. Quality-based intake metrics track outcomes that matter to the firm's bottom line, not just to the intake dashboard.

The metrics that matter: withdrawal rate by rep, average settlement value of cases signed by rep, 90-day retention rate by rep, and rejection-to-signing ratio by lead source. These are not exotic data points. They already exist in your case management system and your intake platform. Nobody is connecting them.

How to Restructure Compensation

This does not require scrapping your bonus structure overnight. It requires adding a quality component that balances the volume incentive. Here is a practical framework.

A rep who signs 25 cases with an 8% withdrawal rate and $45,000 average settlement value earns more than a rep who signs 35 cases with a 16% withdrawal rate and $22,000 average settlement value. The math is straightforward. The first rep is generating more revenue for the firm despite signing fewer cases.

The transition matters. Announce the change 60 days before it takes effect. Share the data that prompted it — withdrawal rates by rep, cost of withdrawn cases, settlement value ranges. Make it clear this is not punitive. It is a recognition that the old model was measuring the wrong thing. The best intake reps will welcome this change because they already know which cases are marginal. They have been signing them anyway because that is what the incentive told them to do.

What Changes When Intake Has Financial Visibility

Something unexpected happens when intake reps can see what happens to their cases after signing. They start making different decisions.

Firms that have implemented quality-based compensation with transparent case outcome data report a consistent pattern: intake reps begin actively flagging low-quality leads. They push back on questionable cases instead of pushing them through. They ask better qualifying questions. They start treating intake as a quality gate rather than a closing floor.

This is not a minor behavioral shift. It changes the entire economics of your intake operation. When reps understand that a withdrawn case costs the firm $2,000 and reduces their own quality score, they self-select. The ones who thrived on volume alone either adapt or reveal that their signing ability was never translating into firm revenue.

The intake team also becomes a powerful source of lead quality intelligence. When reps start flagging which vendors send leads that consistently fail to convert into viable cases, your marketing team gets real-time signal they cannot get from any dashboard. The intake team is talking to every lead, every day. They know which sources produce callers who are shopping, uninjured, or outside your practice area. That qualitative data, combined with the quantitative outcome data, gives you a complete picture of vendor performance.

The Data Infrastructure This Requires

None of this works without connecting two datasets that most firms keep in separate systems: intake activity and case outcomes. You need to trace a line from the intake rep who handled the call, to the retainer that was signed, to the case status 90 days later, to the eventual settlement or withdrawal. That is four data points across two or three systems.

In a spreadsheet, this is a nightmare. It requires manual matching, monthly reconciliation, and someone who remembers to update the withdrawal column three months after the case was signed. In practice, nobody does it consistently. The data gets stale, the matching gets unreliable, and the whole effort collapses within a quarter.

A revenue intelligence platform automates this connection. Case outcomes flow back to the intake record automatically. Withdrawal rates by rep update in real time. Settlement values are attributed to the rep who signed the case. The feedback loop that makes quality-based compensation possible becomes a system, not a spreadsheet project that someone has to maintain.

This is not about adding more software. It is about making visible the connection between what your intake team does today and what it costs your firm six months from now. Until that connection is visible, you are paying bonuses on a metric that does not measure what you think it measures. Your intake team is doing exactly what you are incentivizing them to do. The question is whether you are incentivizing the right thing.